Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.88 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.88 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | LCK | P06239 | 1/20 | 0.53 |
| ▸ | PPARD | Q03181 | 1/20 | 0.53 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.53 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.53 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.46 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.45 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.45 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.45 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL1278216 | 1.00 | GPR84 (0.88) | GPR84FFAR1MAPTLCKPPARD | |
| Propanol SCHEMBL8962521 | 0.96 | GPR84 (0.88) | GPR84FFAR1MAPTLCKPPARD | |
| Octacosanol SCHEMBL28650358 | 0.94 | GPR84 (0.84) | GPR84FFAR1MAPTLCKPPARD | |
| 1,6-Hexanediol SCHEMBL8714304 | 0.94 | GPR84 (0.84) | GPR84FFAR1MAPTLCKPPARD | |
| 1,4-Butanediol SCHEMBL28152529 | 0.94 | GPR84 (0.84) | GPR84FFAR1MAPTLCKPPARD | |
| Dodecanol SCHEMBL15663800 | 0.94 | GPR84 (0.84) | GPR84FFAR1MAPTLCKPPARD | |
| Alcohol SCHEMBL28147971 | 0.94 | GPR84 (0.91) | GPR84FFAR1MAPTLCKPPARD | |
| Alcohol SCHEMBL28203446 | 0.94 | GPR84 (0.91) | GPR84FFAR1MAPTLCKPPARD | |
| Alcohol SCHEMBL8607559 | 0.94 | GPR84 (0.91) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7990074 | 0.94 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 402 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024131725-A1 | TOPICAL PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | Shenzhen Pharmacin Co., Ltd. (CN) | 2024-06-27 | — | — | WO | claimed |
| CN-117440858-A | Plant-derived vesicles incorporating transmembrane proteins | 水通道蛋白有限公司 | 2024-01-23 | — | — | CN | claimed |
| US-20230310440-A1 | RESPIRATORY STIMULANT NASAL FORMULATIONS | ENALARE THERAPEUTICS INC. | 2023-10-05 | — | — | US | claimed |
| WO-2023192602-A2 | RESPIRATORY STIMULANT NASAL FORMULATIONS | ENALARE THERAPEUTICS INC. (US) | 2023-10-05 | — | — | WO | claimed |
| US-20230210857-A1 | RESPIRATORY STIMULANT PARENTERAL FORMULATIONS | ENALARE THERAPEUTICS INC. | 2023-07-06 | — | — | US | claimed |
| WO-2023129502-A1 | RESPIRATORY STIMULANT PARENTERAL FORMULATIONS | ENALARE THERAPEUTICS INC. (US) | 2023-07-06 | — | — | WO | claimed |
| CN-110114121-B | Stabilization of cosmetic compositions comprising fish oil and hydroxylated fatty acid and/or derivative thereof | 联合利华知识产权控股有限公司 | 2022-05-24 | — | — | CN | claimed |
| CN-106061896-B | Inside has the roll complex and preparation method thereof of amphiphilic species | 汉阳大学校产学协力团 | 2019-04-30 | — | — | CN | claimed |
| US-8357676-B2 | Ansamycin formulations and methods of use thereof | INFINITY DISCOVERY, INC. (US) | 2013-01-22 | — | — | US | claimed |
| EP-2126548-A2 | ANSAMYCIN FORMULATIONS AND METHODS OF USE THEREOF | Infinity Discovery, Inc. (US) | 2009-12-02 | — | — | EP | claimed |
| US-20090069281-A1 | Ansamycin formulations and methods of use thereof | AUSTAD BRIAN C | 2009-03-12 | — | — | US | claimed |
| WO-2008073424-A9 | ANSAMYCIN FORMULATIONS AND METHODS OF USE THEREOF | INFINITY DISCOVERY INC (US) | 2008-10-02 | — | — | WO | claimed |
| US-20080221077-A1 | Ansamycin formulations and methods of use thereof | INFINITY DISCOVERY, INC. | 2008-09-11 | — | — | US | claimed |
| WO-2008073424-A2 | ANSAMYCIN FORMULATIONS AND METHODS OF USE THEREOF | INFINITY DISCOVERY, INC. (US) | 2008-06-19 | — | — | WO | claimed |
| US-5006170-A | Thermal ink jet printing, binders, propellants | XEROX CORPORATION (US) | 1991-04-09 | — | — | US | claimed |
| US-4173492-A | Method of preparing coated pigment particles and the product produced thereby | POLLARD EDWARD T | 1979-11-06 | — | — | US | claimed |
| EP-4736154-A1 | ELECTROPHORETIC DEVICE WITH AMBIENT LIGHT SENSOR AND ADAPTIVE WHITENESS RESTORING AND COLOR BALANCING FRONTLIGHT | E Ink Corporation (US) | 2026-05-06 | — | — | EP | disclosed |
| US-12606713-B2 | Electrophoretic media including charge control agents comprising quartenary amines and unsaturated polymeric tails | E INK CORPORATION (US) | 2026-04-21 | — | — | US | disclosed |
| US-4112138-A | Manifold carbonless form and process for the production thereof | THE MEAD CORPORATION (US) | 1978-09-05 | — | — | US | disclosed |
| US-4097619-A | Manifold carbonless form and process for the continuous production thereof | THE MEAD CORPORATION (US) | 1978-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221077-A1 | Ansamycin formulations and methods of use thereof | HSP90B1, HSP90AB1, HSP90AA1 | GPR84 4698/4885FFAR1 4654/4885MAPT 922/4885 |
| US-20230310440-A1 | RESPIRATORY STIMULANT NASAL FORMULATIONS | ADRA2C, MTNR1B, MTNR1A | GPR84 197/4885FFAR1 362/4885MAPT 4651/4885 |
| US-12606713-B2 | Electrophoretic media including charge control agents comprising quartenary amines and unsaturated polymeric tails | AAAS, PARG, PARN | GPR84 2857/4885FFAR1 2790/4885MAPT 80/4885 |
| US-20230210857-A1 | RESPIRATORY STIMULANT PARENTERAL FORMULATIONS | ADRA2C, ADRA1B, CHRM3 | GPR84 190/4885FFAR1 295/4885MAPT 4117/4885 |
| US-20090069281-A1 | Ansamycin formulations and methods of use thereof | HSP90B1, HSP90AB1, HSP90AA1 | GPR84 4698/4885FFAR1 4654/4885MAPT 922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.